論文・総説 - 工藤　篤

221. Mitsunori Y, Tanaka S, Nakamura N, Ban D, Irie T, Noguchi N, Kudo A, Iijima H, Arii S.. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact. J Hepatobiliary Pancreat Sci.. 2012.03;

222. Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S. Importin-α1 as a Novel Prognostic Target for Hepatocellular Carcinoma. Annals of surgical oncology. 2011.02; ( PubMed, DOI )

223. Murakata A, Tanaka S, Mogushi K, Yasen M, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S. Gene expression signature of the gross morphology in hepatocellular carcinoma. Ann Surg. 2011.01; 253 (1): 94-100. ( PubMed, DOI )

224. Mitsunori Y, Kudo A, Nakamura N, Tanaka S, Arii S.. [Significance of contrast enhanced intraoperative ultrasound with Sonazoid for liver metastases from colorectal cancer] Nihon Rinsho.. 2011; Apr;69 (Suppl 3): 320-4.

225. Nakamura N, Irie T, Ochiai T, Kudo A, Itoh K, Tanaka S, Teramoto K, Arii S.. Pancreatoduodenectomy after coronary artery bypass grafting using the right gastroepiploic artery: a case report. Hepatogastroenterology. 2011; Jul-Aug (58(109)): 1137-41. ( PubMed, DOI )

226. Tanaka S, Mogushi K, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Yamamoto M, Kokudo N, Takayama T, Kawasaki S, Sakamoto M, Arii S.. Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study. Hepatology. 2011; Oct (54(4)): 1273-81. ( PubMed, DOI )

227. Uchida Y, Tanaka S, Aihara A, Adikrisna R, Yoshitake K, Matsumura S, Mitsunori Y, Murakata A, Noguchi N, Irie T, Kudo A, Nakamura N, Lai PB, Arii S. Analogy between sphere forming ability and stemness of human hepatoma cells. Oncol Rep. 2010.11; 24 (5): 1147-1151. ( PubMed )

228. Yoshikawa S, Iijima H, Saito M, Tanaka H, Imanishi H, Yoshimoto N, Yoshimoto T, Futatsugi-Yumikura S, Nakanishi K, Tsujimura T, Nishigami T, Kudo A, Arii S, Nishiguchi S. Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model. Hepatol Res. 2010.08; 40 (8): 823-831. ( PubMed, DOI )

229. Arii S, Tanaka S, Mitsunori Y, Nakamura N, Kudo A, Noguchi N, Irie T. Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology. 2010.07; 78 Suppl 1 125-130. ( PubMed, DOI )

230. Tanaka S, Mogushi K, Yasen M, Noguchi N, Kudo A, Nakamura N, Ito K, Miki Y, Inazawa J, Tanaka H, Arii S. Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas. Surgery. 2010.03; 147 (3): 405-414. ( PubMed, DOI )

231. Aihara A, Tanaka S, Yasen M, Matsumura S, Mitsunori Y, Murakata A, Noguchi N, Kudo A, Nakamura N, Ito K, Arii S. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma. J Hepatol. 2009.10; ( PubMed, DOI )

232. Ban D, Kudo A, Sui S, Tanaka S, Nakamura N, Ito K, Suematsu M, Arii S. Decreased Mrp2-dependent bile flow in the post-warm ischemic rat liver. J Surg Res. 2009.05; 153 (2): 310-316. ( PubMed, DOI )

233. Tanaka S, Mogushi K, Yasen M, Noguchi N, Kudo A, Kurokawa T, Nakamura N, Inazawa J, Tanaka H, Arii S. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma. J Am Coll Surg. 2009.03; 208 (3): 368-374. ( PubMed, DOI )

234. Sui S, Kudo A, Suematsu M, Tanaka S, Nakamura N, Ito K, Arii S. Preservation Solutions Alter Mrp2-Dependent Bile Flow in Cold Ischemic Rat Livers. J Surg Res. 2009.01; ( PubMed, DOI )

235. Nakamura N, Kudo A, Ito K, Tanaka S, Arii S. A hepatic lipoma mimicking angiomyolipoma of the liver: report of a case. Surg Today. 2009; 39 (9): 825-828. ( PubMed, DOI )

236. Ui S, Tanaka S, Ito K, Nakamura N, Kudo A, Noguchi N. [Diagnosis of liver cancer and therapy] Gan To Kagaku Ryoho. 2008.10; 35 (10): 1676-1680. ( PubMed )

237. Tanaka S, Taira K, Kudo A, Nakamura N, Ito K, Arii S. Anterior approach for left-sided hepatic resection. Hepatogastroenterology. 2008.09; 55 (86-87): 1760-1763. ( PubMed )

238. Teramoto K, Nakamura N, Ito K, Kudo A, Noguchi N, Takamatsu S, Kawamura T, Tanaka S, Arii S. Strong association between frequency of intermittent inflow occlusion and transient increase in serum liver enzymes after hepatic resection. Hepatogastroenterology. 2008.03; 55 (82-83): 636-640. ( PubMed )

239. Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, Teramoto K, Igari T, Arii S. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma. Hepatogastroenterology. 2008.03; 55 (82-83): 609-614. ( PubMed )

240. Ito K, Kudo A, Nakamura N, Tanaka S, Teramoto K, Arii S. Left-sided portal hypertension caused by serous cystadenoma of the pancreas: report of a case. Surg Today. 2008; 38 (2): 184-187. ( PubMed, DOI )